Radiomics prediction of MGMT promoter methylation in adult diffuse gliomas: a combination of structural MRI, DCE, and DTI by Yuying Liu, Yuying Liu, Zhengyang Zhu, Jianan Zhou, Han Wang, Huiquan Yang, Jinfeng Yin, Yitong Wang, Xin Li, Futao Chen, Qian Li, Zhuoru Jiang, Xi Wu, Danni Ge, Yi Zhang, Xin Zhang, Bing Zhang, Bing Zhang, Bing Zhang, Bing Zhang, Bing Zhang

Subjects: “…MGMT…”
Get full text

Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide by Paolo Tini, Flavio Donnini, Francesco Marampon, Marta Vannini, Tommaso Carfagno, Pierpaolo Pastina, Giovanni Rubino, Salvatore Chibbaro, Alfonso Cerase, Giulio Bagnacci, Armando Perrella, Maria Antonietta Mazzei, Alessandra Pascucci, Vincenzo D’Alonzo, Anna Maria Di Giacomo, Giuseppe Minniti

Subjects: Get full text

IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study by Moez Eid, Dema Alset, Nataliya Timoshkina, Dmitriy Gvaldin, Eduard Rostorguev, Sergey Kavitskiy, Inna Novikova

Subjects: Get full text

The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI‐derived and clinical features, predict adult primary glioblastoma survival by Chang Shu, Qiong Wang, Xiaoling Yan, Jinhuan Wang

Subjects: “…MGMT…”
Get full text

MicroRNAs - Biogênese, funções e características moleculares do glioblastoma by Felipe Amstalden Trevisan, Harley Francisco de Oliveira, Daniela Pretti da Cunha Tirapelli, Carlos Gilberto Carlotti Junior

Subjects: Get full text

Temozolomide-based radio-chemotherapy for newly diagnosed pediatric high-grade gliomas (HIT-HGG-2007): A prospective, multicenter, single-arm, phase II trial by Michael Karremann, Thomas Perwein, André O. von Bueren, Gerrit H. Gielen, Martin Benesch, Gunther Nussbaumer, Lea L. Friker, Andreas Waha, Dominik Sturm, David T.W. Jones, Olaf Witt, Stefan M. Pfister, Matthias Eyrich, Ulrich W. Thomale, Chiara Valentini, Mechthild Krause, Stefaan W. Van Gool, Michael C. Frühwald, Pablo Hernaiz-Driever, Martin Ebinger, Georg Ebetsberger-Dachs, Roman Crazzolara, Christine Haberler, Felix Sahm, Nicolas U. Gerber, Carl Friedrich Classen, Ronald Sträter, Kornelius Kerl, Stefan Rutkowski, Gudrun Fleischhack, Miriam van Buiren, Rolf-Dieter Kortmann, Christian Hagel, Gabriele Calaminus, Andreas Faldum, Monika Warmuth-Metz, Brigitte Bison, Torsten Pietsch, Marion Hoffmann, Robert Kwiecien, Christof M. Kramm

Subjects: Get full text

Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study by Bai Xuexue, Yan Chengrui, Wenbin Ma, Feng Ming, Wu Chao

Subjects: Get full text

Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway by Xiaohang Cui, Anhui Yao, Jinquan Lv, Chi Zhang, Yue Chen, Tingjie Mei, Hengzeng Li, Yahui Wu, Liyun Jia

Subjects: Get full text

Genetic Profile of Primary Brain Tumours and the Degree of Their Resection Versus Survival of Patients Undergoing Surgery and Complementary Oncological Treatment by Lech Grzelak, Sebastian Grzyb, Wiktorai Fiał

Subjects: Get full text

ABERRANT METHYLATION OF THE PROMOTER OF APC, CDH13 AND MGMT GENES IN COLORECTAL CANCER PATIENTS by O. I. Kit, D. I. Vodolazhskiy, K. V. Dvadnenko, I. I. Efimova, E. N. Oleynikova, D. D. Oleynikov, N. N. Timoshkina

Subjects: Get full text

A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for <i>MGMT</i> Gene Promoter Hypermethylation Detection by Marco Macagno, Valeria Pessei, Noemi Congiusta, Luca Lazzari, Sara Erika Bellomo, Fariha Idrees, Alessandro Cavaliere, Filippo Pietrantonio, Alessandra Raimondi, Eleonora Gusmaroli, Maria Giulia Zampino, Lorenzo Gervaso, Davide Ciardiello, Giuseppe Mondello, Armando Santoro, Nicola Personeni, Emanuela Bonoldi, Maria Costanza Aquilano, Emanuele Valtorta, Salvatore Siena, Andrea Sartore-Bianchi, Alessio Amatu, Erica Francesca Bonazzina, Katia Bruna Bencardino, Guido Serini, Silvia Marsoni, Ludovic Barault, Federica Di Nicolantonio, Federica Maione

Subjects: “…MGMT…”
Get full text

MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas by Oleksii Nikolaienko, Garnet L. Anderson, Rowan T. Chlebowski, Su Yon Jung, Holly R. Harris, Stian Knappskog, Per E. Lønning

Subjects: Get full text

Temporal Muscle Thickness as a Prognostic Marker in a Real‐Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis by Lazaros Lazaridis, Christoph Moenninghoff, Elisabeth Bumes, Dorothee Cäcilia Spille, Michael Müther, Tim Schulz, Sina Heider, Sarina Agkatsev, Teresa Schmidt, Tobias Blau, Christoph Oster, Walter Stummer, Almuth Friederike Kessler, Clemens Seidel, Oliver Grauer, Peter Hau, Yahya Ahmadipour, Ulrich Sure, Kathy Keyvani, Ulrich Herrlinger, Christoph Kleinschnitz, Martin Stuschke, Nika Guberina, Ken Herrmann, Cornelius Deuschl, Björn Scheffler, Sied Kebir, Martin Glas

Subjects: Get full text

Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy by Shigeo Ohba, Takao Teranishi, Kazuyasu Matsumura, Masanobu Kumon, Daijiro Kojima, Eiji Fujiwara, Kazutaka Nakao, Kiyonori Kuwahara, Kazuhiro Murayama, Eriel Sandika Pareira, Seiji Yamada, Masahiro Joko, Shunsuke Nakae, Jun Muto, Yuya Nishiyama, Kazuhide Adachi, Hikaru Sasaki, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose

Subjects: Get full text

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma by Jack Patrick Gleeson, Fergus Keane, Niamh M. Keegan, Emin Mammadov, Emily Harrold, Abdullah Alhusaini, Jeffrey Harte, Austin Eakin‐Love, Philip J. O'Halloran, Stephen MacNally, Bryan T. Hennessy, Oscar S. Breathnach, Liam Grogan, Patrick G. Morris

Subjects: Get full text

The impact of the subventricular zone invasion types and MGMT methylation status on tumor recurrence and prognosis in glioblastoma by Zhiying Shao, Hao Yan, Min Zhu, Zhengyang Liu, Ziqin Chen, Weiqi Li, Chenyang Wang, Longzhen Zhang, Junnian Zheng

Subjects: Get full text

Novel Pathways of Oxidative and Nitrosative Inactivation of the Human MGMT Protein in Colon Cancer and Glioblastoma Cells: Increased Efficacy of Alkylating Agents In Vitro and In V... by Debasish Basak, Agm Mostofa, Hanumantha Rao Madala, Kalkunte S. Srivenugopal

Subjects: “…MGMT…”
Get full text

MORPHOLOGIC AND MOLECULAR FEATURES OF PRIMARY GLIOBLASTOMA IN PATIENTS SURVIVING MORE THAN 3 YEARS by M. V. Matsko, D. E. Matsko, N. M. Volkov, A. Yu. Ulitin, V. M. Moiseenko, E. N. Imyanitov, A. G. Iyevleva

Subjects: Get full text

Prediction of MGMT methylation status in glioblastoma patients based on radiomics feature extracted from intratumoral and peritumoral MRI imaging by Wang-Sheng Chen, Fang-Xiong Fu, Qin-Lei Cai, Fei Wang, Xue-Hua Wang, Lan Hong, Li Su

Subjects: Get full text

Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas by D. V. Tabakov, A. N. Katargin, A. M. Stroganova, A. I. Senderovich, D. R. Naskhletashvili, N. P. Kiseljova

Subjects: Get full text